Fan Luo

1.3k total citations
57 papers, 761 citations indexed

About

Fan Luo is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fan Luo has authored 57 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 22 papers in Oncology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fan Luo's work include Lung Cancer Treatments and Mutations (11 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). Fan Luo is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). Fan Luo collaborates with scholars based in China, United States and Ghana. Fan Luo's co-authors include Hongyun Zhao, Yan Huang, Feiteng Lu, Jiaxin Cao, Ting Zhou, Wenjuan Ma, Zhonghan Zhang, Min Luo, Liwu Fu and Fang Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Fan Luo

56 papers receiving 748 citations

Peers

Countries citing papers authored by Fan Luo

Since Specialization

Citations

This map shows the geographic impact of Fan Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fan Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fan Luo more than expected).

Fields of papers citing papers by Fan Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fan Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fan Luo. The network helps show where Fan Luo may publish in the future.

Co-authorship network of co-authors of Fan Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Fan Luo. A scholar is included among the top collaborators of Fan Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fan Luo. Fan Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Peptide loaded self-healing hydrogel promotes diabetic skin wound healing through macrophage orchestration and inflammation inhibition 2025 ·Materials Today Bio ·(unknown), (unknown), Shuwen Xiang, Yuchen Zhang, Fan Luo, Xingdan Liu, Xiaoli Zhao, Liping Ouyang	8
2	Urate-lowering therapy and kidney outcomes in patients with chronic kidney disease and hyperuricemia 2025 ·Signal Transduction and Targeted Therapy ·Sheng Nie, Shi-Yu Zhou, Ruixuan Chen, (unknown), (unknown), Jiao Liu, (unknown), Xian Shao, (unknown), Licong Su, Fan Luo, Xin Xu, Fan Fan Hou	0
3	Prophylactic antiviral therapy and all-cause mortality in cancer patients with hepatitis B e antigen-negative chronic hepatitis B virus infection receiving immunosuppressive therapy 2025 ·JNCI Journal of the National Cancer Institute ·Sheng Nie, (unknown), Licong Su, Shi-Yu Zhou, Yanqin Li, Ruixuan Chen, Fan Luo, Qi Gao, Yuxin Lin, Zhixin Guo, Xin Xu, Guobao Wang, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
4	Discontinuation of Renin-Angiotensin System Inhibitors during Acute Kidney Injury Episode and All-Cause Mortality 2025 ·Journal of the American Society of Nephrology ·Sheng Nie, Yanqin Li, (unknown), (unknown), Xian Shao, (unknown), Shi-Yu Zhou, Licong Su, Ruixuan Chen, Fan Luo, Xin Xu, Fan Fan Hou, (unknown)	1
5	Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma 2024 ·npj Precision Oncology ·Yuxiang Ma, Huaqiang Zhou, Fan Luo, Yang Zhang, Changbin Zhu, Weiwei Li, (unknown), (unknown), Jinhui Xue, Yuanyuan Zhao, Wenfeng Fang, Yunpeng Yang, Yan Huang, (unknown), Hongyun Zhao	6
6	Genomic and transcriptomic profiling of combined small-cell lung cancer through microdissection: unveiling the transformational pathway of mixed subtype 2024 ·Journal of Translational Medicine ·Wenjuan Ma, Ting Zhou, Mengmeng Song, Jiaqing Liu, Gang Chen, Jianhua Zhan, Liyan Ji, Fan Luo, Xuan Gao, Pansong Li, Xuefeng Xia, Yan Huang, Li Zhang	1
7	Comparative Effectiveness and Safety of Atorvastatin Versus Rosuvastatin 2024 ·Annals of Internal Medicine ·Shiyu Zhou, Ruixuan Chen, Jiao Liu, Zhixin Guo, Licong Su, Yanqin Li, Xiaodong Zhang, Fan Luo, Qi Gao, (unknown), (unknown), (unknown), Xin Xu, Sheng Nie	11
8	HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotype 2024 ·Journal for ImmunoTherapy of Cancer ·Fan Luo, Jiaxin Cao, (unknown), (unknown), (unknown), Xue Bai, Wenjuan Ma, (unknown), Ting Zhou, Jianhua Zhan, Yan Huang, Yunpeng Yang, (unknown), (unknown)	3
9	Metabolomics analysis reveals crucial effects of arbuscular mycorrhizal fungi on the metabolism of quality compounds in shoots and roots of Camellia sinensis L 2024 ·Plant Physiology and Biochemistry ·(unknown), Zheng Zhang, (unknown), Qiuhong Wang, (unknown), (unknown), Lan Zhang, Wenyan Han, Fan Luo, Xin Li	2
10	PQR309, a dual PI3K/mTOR inhibitor, synergizes with gemcitabine by impairing the GSK-3β and STAT3/HSP60 signaling pathways to treat nasopharyngeal carcinoma 2024 ·Cell Death and Disease ·Jiaxin Cao, (unknown), Qun Chen, (unknown), Feiteng Lu, (unknown), Jianhua Zhan, Wenjuan Ma, Ting Zhou, Yan Huang, Fan Luo, Hongyun Zhao	1
11	The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation 2023 ·Cellular and Molecular Immunology ·Fan Luo, Han Li, Wenjuan Ma, Jiaxin Cao, Qun Chen, Feiteng Lu, Miao‐Zhen Qiu, Penghui Zhou, (unknown), (unknown), Jianhua Zhan, Ting Zhou, Qiuyun Luo, Wentao Pan, Lin Zhang, (unknown), Yan Huang, Li Zhang, Dajun Yang, Hongyun Zhao	37
12	Predictive value of immunotherapy-induced inflammation indexes: dynamic changes in patients with nasopharyngeal carcinoma receiving immune checkpoint inhibitors 2023 ·Annals of Medicine ·Jiaxin Cao, Qun Chen, Xue Bai, (unknown), Wenjuan Ma, (unknown), Feiteng Lu, Ting Zhou, Jianhua Zhan, Yan Huang, Yunpeng Yang, Fan Luo, Hongyun Zhao	16
13	Centralized health management based on hot spring resort improves physical examination indicators and sleep quality in people at high risk of chronic diseases: a randomized controlled trial 2023 ·International Journal of Biometeorology ·Yu Chen, Fan Luo, (unknown), Qizhong Qin, (unknown), (unknown), Ying Huang, (unknown), Wen Wang, Qiuling Shi, Qirui Wang, (unknown), Ting Wang, Jishan Jiang	1
14	Kidney Biopsy in Patients With Monoclonal Gammopathy: A Multicenter Retrospective Cohort Study 2021 ·Frontiers in Medicine ·Sheng Nie, Mengyi Wang, Qijun Wan, Yaozhong Kong, (unknown), Nan Jia, Xiaodong Zhang, Fan Luo, Xiaoting Liu, Lin Wang, Yue Cao, Ruixuan Chen, Ming Zhao, David Yiu Leung Chan, Guobao Wang	4
15	Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes 2021 ·Cancer Cell International ·Fan Luo, Jiaxin Cao, Feiteng Lu, (unknown), Wenjuan Ma, Yan Huang, Li Zhang, Hongyun Zhao	11
16	Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathway 2021 ·Cell Death and Disease ·Fan Luo, Feiteng Lu, Miao‐Zhen Qiu, Ting Zhou, Wenjuan Ma, Min Luo, (unknown), Qiuyun Luo, Wentao Pan, Lin Zhang, (unknown), Zhonghan Zhang, Jiaxin Cao, Hongyun Zhao, Li Zhang, Dajun Yang	19
17	Dual blockade of EGFR and VEGFR pathways: Results from a pilot study evaluating apatinib plus gefitinib as a first‐line treatment for advanced EGFR‐mutant non‐small cell lung cancer 2020 ·SHILAP Revista de lepidopterología ·Zhonghan Zhang, Yang Zhang, Fan Luo, Yuxiang Ma, Wenfeng Fang, Jing Zhan, Li Su, Yunpeng Yang, Yuanyuan Zhao, Shaodong Hong, Ting Zhou, Yaxiong Zhang, Shen Zhao, Yan Huang, Hongyun Zhao, Li Zhang	15
18	RNA-Seq Revealed a Circular RNA-microRNA-mRNA Regulatory Network in Hantaan Virus Infection 2020 ·Frontiers in Cellular and Infection Microbiology ·Shuang Lu, Ni Zhu, Weiwei Guo, Xin Wang, (unknown), Jie Yan, Cuiping Jiang, (unknown), (unknown), Xiaohan Wu, Yuanyuan Liu, Hairong Xiong, Liangjun Chen, (unknown), Fan Luo, Wei Hou	91
19	The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706) 2019 ·Cancer Communications ·Zhonghan Zhang, Fan Luo, Yang Zhang, Yuxiang Ma, Shaodong Hong, Yunpeng Yang, Wenfeng Fang, Yan Huang, Li Zhang, Hongyun Zhao	18
20	Characterization of the interaction interface and conformational dynamics of human TGIF1 homeodomain upon the binding of consensus DNA 2018 ·Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ·Shuangli Li, Rui Hu, (unknown), Dong Long, Fan Luo, Xin Zhou, Xu Zhang, Maili Liu, Jiang Zhu, Yunhuang Yang	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact